Public Profile

Purdue Pharma Inc.

Purdue Pharma Inc., a prominent player in the pharmaceutical industry, is headquartered in California and operates extensively across North America. Founded in 1892, the company has a rich history marked by significant milestones, including the development of innovative pain management solutions. Purdue Pharma is best known for its unique formulations of prescription medications, particularly in the realm of pain relief. Their flagship product, OxyContin, revolutionised the treatment of chronic pain, although it has also been the subject of considerable scrutiny. With a strong market position, Purdue Pharma continues to focus on advancing therapeutic options while navigating the complexities of the healthcare landscape. The company remains committed to addressing the needs of patients and healthcare providers through its ongoing research and development efforts.

DitchCarbon Score

How does Purdue Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Purdue Pharma Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Purdue Pharma Inc.'s reported carbon emissions

Purdue Pharma Inc., headquartered in California, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This lack of information suggests that Purdue Pharma may not have established formal commitments to reduce its carbon footprint or address climate change impacts at this time. In the context of the pharmaceutical industry, companies are increasingly expected to adopt transparent climate strategies and set measurable targets to mitigate their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Purdue Pharma Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Purdue Pharma Inc. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Purdue Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

HLS Therapeutics Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Hls Pharmacies, Inc.

US
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 1 day ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Paladin Limited

HK
Real estate services (70)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers